1. Home
  2. CBAT vs VNRX Comparison

CBAT vs VNRX Comparison

Compare CBAT & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBAT
  • VNRX
  • Stock Information
  • Founded
  • CBAT 1999
  • VNRX N/A
  • Country
  • CBAT China
  • VNRX United States
  • Employees
  • CBAT N/A
  • VNRX N/A
  • Industry
  • CBAT Industrial Machinery/Components
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • CBAT Miscellaneous
  • VNRX Health Care
  • Exchange
  • CBAT Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • CBAT 75.2M
  • VNRX 67.2M
  • IPO Year
  • CBAT N/A
  • VNRX N/A
  • Fundamental
  • Price
  • CBAT $0.86
  • VNRX $0.64
  • Analyst Decision
  • CBAT
  • VNRX Strong Buy
  • Analyst Count
  • CBAT 0
  • VNRX 4
  • Target Price
  • CBAT N/A
  • VNRX $4.17
  • AVG Volume (30 Days)
  • CBAT 261.4K
  • VNRX 524.2K
  • Earning Date
  • CBAT 11-12-2024
  • VNRX 11-14-2024
  • Dividend Yield
  • CBAT N/A
  • VNRX N/A
  • EPS Growth
  • CBAT N/A
  • VNRX N/A
  • EPS
  • CBAT 0.12
  • VNRX N/A
  • Revenue
  • CBAT $207,423,403.00
  • VNRX $1,285,827.00
  • Revenue This Year
  • CBAT $10.76
  • VNRX $180.66
  • Revenue Next Year
  • CBAT $15.32
  • VNRX $558.69
  • P/E Ratio
  • CBAT $6.95
  • VNRX N/A
  • Revenue Growth
  • CBAT 2.32
  • VNRX 97.50
  • 52 Week Low
  • CBAT $0.82
  • VNRX $0.43
  • 52 Week High
  • CBAT $2.08
  • VNRX $1.23
  • Technical
  • Relative Strength Index (RSI)
  • CBAT 38.12
  • VNRX 49.57
  • Support Level
  • CBAT $0.82
  • VNRX $0.57
  • Resistance Level
  • CBAT $0.89
  • VNRX $0.68
  • Average True Range (ATR)
  • CBAT 0.05
  • VNRX 0.08
  • MACD
  • CBAT -0.00
  • VNRX -0.00
  • Stochastic Oscillator
  • CBAT 14.23
  • VNRX 58.40

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization and distribution of a variety of standard and customized lithium-ion high-power rechargeable batteries. The company operates in two operating segments: CBAK's segment mainly includes the manufacture, commercialization and distribution of a wide variety of standard and customized lithium ion rechargeable batteries for use in a wide array of applications. Hitrans' segment mainly includes the development and manufacturing of NCM precursor and cathode materials. Geographically, it generates a majority of its revenue from Mainland China and also has an operation in Europe, the United States, Korea, and Other Countries.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: